BIOMAT Database Logo BIOMAT Database Logo

Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. 1995

M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro

UI MeSH Term Description Entries
D009675 Novobiocin An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) Crystallinic Acid,Streptonivicin,Novobiocin Calcium,Novobiocin Sodium,Novobiocin, Monosodium Salt,Calcium, Novobiocin,Monosodium Salt Novobiocin,Sodium, Novobiocin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial
D016984 Enterococcus faecium A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source. Streptococcus faecium

Related Publications

M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Colonization pattern of vancomycin-resistant Enterococcus faecium.
August 1994, American journal of infection control,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Vancomycin-resistant Enterococcus faecium colonization in children.
February 1999, Journal of clinical microbiology,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.
March 2013, Infection and immunity,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
October 1997, Infection control and hospital epidemiology,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
December 1995, Infection control and hospital epidemiology,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
July 1995, Archives of internal medicine,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.
September 2020, Acta clinica Croatica,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Outbreak of colonization and infection with vancomycin-resistant Enterococcus faecium in a French university hospital.
September 2006, Infection control and hospital epidemiology,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
[Vancomycin resistant Enterococcus faecium].
June 2000, Revista medica de Chile,
M A Montecalvo, and H Horowitz, and G P Wormser, and K Seiter, and C A Carbonaro
Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients.
May 2020, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!